2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mengesha AE et al. | Binary blend of glyceryl monooleate and glyceryl monostearate for magnetically induced thermo-responsive local drug delivery system. | 2013 | Pharm. Res. | pmid:24158728 |
| Swarnakar NK et al. | Enhanced oromucosal delivery of progesterone via hexosomes. | 2007 | Pharm. Res. | pmid:17828445 |
| Kararli TT et al. | Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations. | 1992 | Pharm. Res. | pmid:1409372 |
| Kararli TT et al. | Oral delivery of a renin inhibitor compound using emulsion formulations. | 1992 | Pharm. Res. | pmid:1438002 |
| Lopes LB et al. | Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. | 2006 | Pharm. Res. | pmid:16715364 |
| Geraghty PB et al. | The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels. | 1996 | Pharm. Res. | pmid:8865324 |
| Patil SS et al. | Mapping ion-induced mesophasic transformation in lyotropic in situ gelling system and its correlation with pharmaceutical performance. | 2013 | Pharm. Res. | pmid:23595880 |
| Fatouros DG et al. | Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products. | 2009 | Pharm. Res. | pmid:19003522 |
| Kulkarni CV et al. | Monoolein: a magic lipid? | 2011 | Phys Chem Chem Phys | pmid:21183976 |
| Angelov B et al. | SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers. | 2011 | Phys Chem Chem Phys | pmid:21079857 |